OA07.01 Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.269
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Surgical Management of Oligometastatic Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

MA25.03 Defining Oligometastatic Non-Small Cell Lung Cancer (NSCLC): An Evolving Multidisciplinary Expert Opinion

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Oligometastatic Non-Small Cell Lung Cancer: Is There a Role for Locoregional Therapy?

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Surgical Approach in Oligometastatic Non-Small Cell Lung Cancer

Annals of Translational Medicine
Medicine
2018English

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently With Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Cost-Effectiveness of First-Line Therapy for Advanced Non-Small Cell Lung Cancer (Nsclc)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Pulmonary Emphysema Have a High Risk of Radiation Pneumonitis Following Definitive Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Phase II Study of ACNU in Non-Small-Cell Lung Cancer: EORTC Study 08872

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1991English

Keeping Surgery Relevant in Oligometastatic Non-Small Cell Lung Cancer

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy